GE HealthCare Technologies Inc (GEHC) concluded trading on Thursday at a closing price of $93.48, with 7.41 million shares of worth about $692.29 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.06% during that period and on February 13, 2025 the price saw a gain of about 8.82%. Currently the company’s common shares owned by public are about 456.85M shares, out of which, 442.49M shares are available for trading.
Stock saw a price change of 5.57% in past 5 days and over the past one month there was a price change of 11.11%. Year-to-date (YTD), GEHC shares are showing a performance of 19.57% which increased to 12.40% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $74.51 but also hit the highest price of $94.55 during that period. The average intraday trading volume for GE HealthCare Technologies Inc shares is 2.91 million. The stock is currently trading 6.50% above its 20-day simple moving average (SMA20), while that difference is up 11.49% for SMA50 and it goes to 11.82% higher than SMA200.
GE HealthCare Technologies Inc (NASDAQ: GEHC) currently have 456.85M outstanding shares and institutions hold larger chunk of about 83.86% of that.
The stock has a current market capitalization of $42.71B and its 3Y-monthly beta is at 1.34. PE ratio of stock for trailing 12 months is 25.60, while it has posted earnings per share of $3.65 in the same period. Its PEG reads 2.82 and has Quick Ratio of 0.94 while making debt-to-equity ratio of 1.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GEHC, volatility over the week remained 2.46% while standing at 2.28% over the month.
Stock’s fiscal year EPS is expected to rise by 4.50% while it is estimated to increase by 11.53% in next year. EPS is likely to grow at an annualized rate of 9.08% for next 5-years, compared to annual growth of -2.54% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on January 08, 2025 offering a Buy rating for the stock and assigned a target price range of between $95 and $103 to it. Coverage by UBS stated GE HealthCare Technologies Inc (GEHC) stock as a Sell in their note to investors on September 26, 2024, suggesting a price target of $74 for the stock. On September 18, 2024, BTIG Research Upgrade their recommendations, while on September 09, 2024, JP Morgan Initiated their ratings for the stock with a price target of $90. Stock get a Buy rating from Stifel on August 06, 2024.
